This is an updated version of our inaugural “BluePaper,” originally published in February 2014, on a topic that is highly relevant to prospective investors in Israeli equities. We contrast the perception of risk in Israeli markets versus the reality of economic resilience and correlations with global rather than local events.
The resilience and strength of global equity markets - including Israeli equities as measured by the BlueStar Israel Global Index - is not only perplexing but worrying to some. However one must continue to analyze what matters most to equity markets and do one’s best to cancel out background noise.
This article focuses on how one particular subset of indexing—single-country funds based on arguably superior index construction methodology—is changing one element of the international investing landscape.
Despite the military conflict with Hamas in Gaza, Israeli equities generally outperformed their Developed Market peers in July. This is a testament to the resilience of Israeli equities and companies in the face of war and strong geopolitical headwinds.
The BlueStar Israel Global Index and the BlueStar Israel Global Technology Index (“BIGITech”) underwent their semi-annual rebalance and reconstitution. As a result of increased IPO activity during the first and second quarters of 2014, BIGI added a net of 12 new constituents and BIGITech added a net of four new constituents...
The BlueStar Israel Global Index ™ (“BIGI®”) rose 2.45% in June after two consecutive monthly declines in April and May. Israeli Global Equities outperformed most other global equity benchmarks including the S&P 500, while domestic Israeli equities as measured by the TA-100 and MSCI Israel indexes were down in June...
ISRA began trading on the New York Stock Exchange on June 26, 2013, with less than $10 million in assets under management, becoming the second Israeli equities ETF to hit the market. ISRA now boasts approximately $48 million in assets under management, and is growing in recognition for investment in Israeli Global Equities